Fibrosis Quística: mutaciones más frecuentes en la población mundial Cystic fibrosis: more frequent mutations in world population

Fibrosis Quística: mutaciones más frecuentes en la población mundial Cystic fibrosis: more frequent mutations in world population

La Fibrosis Quística (FQ) es la enfermedad autosómica recesiva más común en la población Caucásica, con una incidencia en un rango entre uno en 1700 y uno en 7700. Desde que fue clonado el gen regulador de transmembrana de la FQ (CFTR) e identificada la mutación principal F508del, más de 1300 mutaci...

Full description

Bibliographic Details
Main Author:	Teresa Collazo Mesa
Format:	Article
Language:	Spanish
Published:	Centro Nacional de Información de Ciencias Médicas. Editorial de Ciencias Médicas (ECIMED) 2008-06-01
Series:	Revista Cubana de Investigaciones Biomédicas
Subjects:	Fibrosis Quística gen CFTR proteína CFTR mutaciones polimorfismos Cystic fibrosis CFTR gen CFTR protein mutations polymorphs
Online Access:	http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002008000200004

Similar Items

Caracterización clínica y genética de la fibrosis quística en la provincia de Holguín
by: Elayne Esther Santana Hernández, et al.

Fibrosis Quística Pulmonar, Gástrica y Gastro-Pulmonar en la Actualidad: Una Revisión Sistémica
by: C Bocanegra Amaya, et al.
Published: (2015-01-01)

New Therapies to Correct the Cystic Fibrosis Basic Defect
by: Christelle Bergeron, et al.
Published: (2021-06-01)

Activity of lumacaftor is not conserved in zebrafish Cftr bearing the major cystic fibrosis‐causing mutation
by: Onofrio Laselva, et al.
Published: (2019-10-01)

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
by: Iwona Pranke, et al.
Published: (2019-02-01)

Development of a method to detect three frequent mutations in the CFTR gene using allele-specific real time PCR
by: Juan E Figueredo-Lago, et al.

Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors
by: Giulia Amico, et al.
Published: (2019-11-01)

Comportament funcional heterogeni de les mutacions "missense" a l'extrem N-terminal de CFTR
by: González Gené, Gemma
Published: (2008)

Molecular Diagnosis and Genetic Counseling of Cystic Fibrosis and Related Disorders: New Challenges
by: Thierry Bienvenu, et al.
Published: (2020-06-01)

Lung Microbiome in Cystic Fibrosis
by: Filippo Scialo, et al.
Published: (2021-01-01)

Profile of tezacaftor/ivacaftor combination and its potential in the treatment of cystic fibrosis
by: Shiferaw D, et al.
Published: (2019-08-01)

Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein
by: Virginia Spanò, et al.
Published: (2021-02-01)

A retrospective study of cases diagnosed with cystic fibrosis at a single care center in Syria
by: Raghad Al-Baba, et al.
Published: (2021-06-01)

Pancreatitis in A Patient with Cystic Fibrosis Taking Ivacaftor
by: Argyri Petrocheilou, et al.
Published: (2020-01-01)

Long-Term Pulmonal Therapy of Cystic Fibrosis-Patients with Amitriptyline
by: Constantin Adams, et al.
Published: (2016-07-01)

Molecular and Functional Basis of Cystic Fibrosis in Indian Patients: Genetic, Diagnostic and Therapeutic Implications
by: Rajendra Prasad
Published: (2018-10-01)

Expression and functional significance of the cystic fibrosis transmembrane conductance regulator (CFTR) in human mast cells
by: Dry, Ren
Published: (2009)

Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation
by: Isabelle Sermet-Gaudelus
Published: (2013-03-01)

CFTR Lifecycle Map—A Systems Medicine Model of CFTR Maturation to Predict Possible Active Compound Combinations
by: Liza Vinhoven, et al.
Published: (2021-07-01)

Characterization of clinical and genetic spectrum of Chinese patients with cystic fibrosis
by: Keqiang Liu, et al.
Published: (2020-06-01)

Analysis of Ivacaftor drug approval for cystic fibrosis patients with gating mutations.
by: Nemirajaiah, S.
Published: (2021-08-01)

Demographic characteristics, clinical and laboratory features, and the distribution of pathogenic variants in the CFTR gene in the Cypriot cystic fibrosis (CF) population demonstrate the utility of a national CF patient registry
by: Panayiotis K. Yiallouros, et al.
Published: (2021-10-01)

Characterization of two rat models of cystic fibrosis—KO and F508del CFTR—Generated by Crispr‐Cas9
by: Elise Dreano, et al.
Published: (2019-12-01)

The Expression and Characterization of Human Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Tobacco
by: Witt, William T.
Published: (2014)

High-Dose Ibuprofen in Cystic Fibrosis
by: Larry C. Lands, et al.
Published: (2010-07-01)

Cystic Fibrosis, CFTR, and Colorectal Cancer
by: Patricia Scott, et al.
Published: (2020-04-01)

Analysis of CFTR Gene Mutations in Children with Cystic Fibrosis, First Report from North-East of Iran
by: Atieh Mehdizadeh Hakkak, et al.
Published: (2013-08-01)

Atypical cystic fibrosis diagnosed in a14-year-old boy
by: Iwona Stelmach, et al.
Published: (2016-06-01)

Genotype-phenotype correlation in cystic fibrosis patients bearing [H939R;H949L] allele
by: Angela Polizzi, et al.
Published: (2011-01-01)

Downregulation of the Cl-/HCO3-Exchanger Pendrin in Kidneys of Mice with Cystic Fibrosis: Role in the Pathogenesis of Metabolic Alkalosis
by: Mujan Varasteh Kia, et al.
Published: (2018-02-01)

State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (<i>CFTR</i>) Modulators and Triple-Combination Therapy
by: Aniello Meoli, et al.
Published: (2021-09-01)

Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy
by: Nardone Anna, et al.
Published: (2004-04-01)

THE CLINICAL AND GENETIC CHARACTERISTICS AND OUTCOMES OF MECONIUM ILEUS IN CYSTIC FIBROSIS
by: E. I. Kondratyeva, et al.
Published: (2017-01-01)

Intestinal Dysfunction in Cystic Fibrosis
by: Vitko, Megan Sue
Published: (2016)

Targeted sequencing reveals complex, phenotype-correlated genotypes in cystic fibrosis
by: Maxim Ivanov, et al.
Published: (2018-02-01)

Identification of a novel large deletion and other copy number variations in the CFTR gene in patients with Cystic Fibrosis from a multiethnic population
by: Raisa da Silva Martins, et al.
Published: (2019-07-01)

Phenotyping of Rare <i>CFTR</i> Mutations Reveals Distinct Trafficking and Functional Defects
by: Marjolein Ensinck, et al.
Published: (2020-03-01)

Reproductive system status and the algorithm to solve fertility issues in men with cystic fibrosis
by: S. A. Repina, et al.
Published: (2019-02-01)

Drug-induced dyspnea versus cystic fibrosis exacerbation: a diagnostic dilemma
by: Walayat S, et al.
Published: (2017-07-01)

Case Report: White Colored Stool: An Early Sign of Cystic Fibrosis in Infants
by: Jing Guo, et al.
Published: (2021-04-01)

Cannot write session to /tmp/vufind_sessions/sess_bab3r3m03gromtjb52s11uf9u6